PharmaVentures acts as the exclusive M&A advisor on the successful sale of Phasefocus to Bruker
Bruker(BRKR) Prnewswire·2024-03-19 17:00
PharmaVentures与Phasefocus Holdings Limited合作 - PharmaVentures作为Phasefocus Holdings Limited的独家顾问,协助其被Bruker收购[1] - PharmaVentures的董事Adrian Dawkes表示,此次交易为Phasefocus股东带来了成功的结果,获得了Bruker的商业认可[3] Phasefocus的业务和产品 - Phasefocus是一家专注于成像、图像处理算法和成像平台的私人公司[2] - Phasefocus开发了一种名为Livecyte的新型光学显微镜[2]